Skip to main content
Clinical Trials/NCT01405092
NCT01405092CompletedNot Applicable

Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy)

Dallas VA Medical Center2 sites in 1 country28 target enrollmentStarted: April 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
28
Locations
2
Primary Endpoint
compare number of hypotensive events in treatment versus control arms

Study Overview

Brief Summary

Use of on-line blood volume monitoring during continuous renal replacement therapy can improve volume management in acute kidney injury patients requiring renal replacement

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with kidney injury requiring continuous renal replacement therapy and volume removal

Exclusion Criteria

  • unable to provide or obtain patient consent
  • not expected to survive 48 hours

Outcomes

Primary Outcomes

compare number of hypotensive events in treatment versus control arms

Time Frame: 24 hour for each arm

compare the number of hypotensive events during use of crit-line monitor over 24 hour period versus during control 24 hour period

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Fed
Responsible Party
Principal Investigator
Principal Investigator

Devasmita C. Dev MD

Director of In-center and Home Dialysis

Dallas VA Medical Center

Study Sites (2)

Loading locations...

Similar Trials